Abstract
The urgency of the problem of endometrial hyperplastic processes is due to the high risk of their malignancy, especially in women in peri- and postmenopause. The frequency of malignancy of endometrial hyperplastic processes varies within a fairly wide range (0.25–50%) and is determined by the morphological features of the disease, the duration of its recurrence, and the age of the patients. The aim of our work is to optimize the tactics of managing women with hyperplastic processes and endometrial cancer based on the development of an algorithm for diagnosing, treating and predicting the outcomes of therapy for this pathology using modern medical technologies. The complex use of clinical, laboratory, instrumental methods allows you to choose the best methods for diagnosing and treating endometrial hyperplastic processes.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
